{"name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","slug":"i-r-c-c-s-ospedale-galeazzi-sant-ambrogio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Didrogyl","genericName":"Didrogyl","slug":"didrogyl","indication":"Other","status":"marketed"},{"name":"ASC secretome","genericName":"ASC secretome","slug":"asc-secretome","indication":"Other","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"clopidogrel/abciximab","genericName":"clopidogrel/abciximab","slug":"clopidogrel-abciximab","indication":"Acute coronary syndrome and percutaneous coronary intervention","status":"marketed"},{"name":"prasugrel/bivalirudin","genericName":"prasugrel/bivalirudin","slug":"prasugrel-bivalirudin","indication":"Acute coronary syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI)","status":"marketed"}]}],"pipeline":[{"name":"Didrogyl","genericName":"Didrogyl","slug":"didrogyl","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ASC secretome","genericName":"ASC secretome","slug":"asc-secretome","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"clopidogrel/abciximab","genericName":"clopidogrel/abciximab","slug":"clopidogrel-abciximab","phase":"marketed","mechanism":"This combination uses clopidogrel to inhibit platelet aggregation via P2Y12 receptor blockade and abciximab to block the glycoprotein IIb/IIIa receptor, providing dual antiplatelet effects.","indications":["Acute coronary syndrome and percutaneous coronary intervention"],"catalyst":""},{"name":"prasugrel/bivalirudin","genericName":"prasugrel/bivalirudin","slug":"prasugrel-bivalirudin","phase":"marketed","mechanism":"Prasugrel and bivalirudin are combined to provide dual antiplatelet and anticoagulant activity for acute coronary syndrome management.","indications":["Acute coronary syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNbzgxb1NicTJGWXFkQnAzUTVaYW5xbUFqZW53dVJoRFEzSnV1a3R5STc1ZHMwcmhXY0Y4VW5MbXVnaFkxQ1plMjMzR2kzTHI5akNnM3pxcEQzUmZhbVktRTFXeE1PZy1xM0NSb1lscFU0N3pXTVQ1TzZrMnMwenZCMjdRZEV1UW1wQ1BidWdwX3ZaNXNqcC1MS21GdmMzYjNoZFRUS1BjNmxqMjBjcnRDeTBWVzJOQVFIQUVxWV84amFhT0d5VmdmUE95VzQwcW5sd3lCZnNFdmhDalcxRE53NGZDWVYydUtmUF9LamdIeWNlU3V0MG84NC1B?oc=5","date":"2025-07-02","type":"pipeline","source":"European Medical Journal","summary":"Editor's Pick: Transcatheter Aortic Valve Implantation in Patients with Pure Non-Calcified Aortic Regurgitation - European Medical Journal","headline":"Editor's Pick: Transcatheter Aortic Valve Implantation in Patients with Pure Non-Calcified Aortic Regurgitation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxORHJ3LUZvYlhfTHd2VFBDeGFZRV9NeGIzMWU0NEFEU1A3eU1JZktUTHk1MkNEQlNhUm8yN3NYeWlyb3hQbDhZOTBpMlpjbDM1NTRISERTWWdkTFNkWm16NWlEN0hmNHhhOV9FVlN6cDNDaHdsbWhwWDRzR3hScEpJUUp1OXlkYkdLXzYzUnlJMjNMVkt2UDVBZm1BdXM3dHNIMmV4RWxOWjlad2ZlbENhOFdyV1YtN0hnZnJQS2E0MndBTHhKY2VGeXR3TTNYaUdsRzJHcDd3NV8wX0xfcEpMVUVwdERsQTFoc25ScFdzNkhOQlJZMkt1Zzk5bjRWRmRQb3I2cEs1cjZaTkpydHJZSjE2WS14a0l6Um5WeTBVNDBCSXZQNjlPLUMtakZHeG5BRllKTWN4U3FHLWFOUEJDWDJsTGE5Zw?oc=5","date":"2024-07-25","type":"pipeline","source":"European Medical Journal","summary":"Comparison of Lung Ultrasound B-Lines and Pleural Line Alterations with Automated Quantitative CT: Is it Possible to Overcome the Limitations of the Ultrasound Method? - European Medical Journal","headline":"Comparison of Lung Ultrasound B-Lines and Pleural Line Alterations with Automated Quantitative CT: Is it Possible to Ove","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":3,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}